TS1519663519	sideeffect 473 486	pro-coagulant
TS1619663519	drug 656 756	Pyridinium , 3- [[2- ( methylsulfonyl ) hydrazino] carbonyl]-1- [2-oxo-2-2-thienyl ) ethyl]-chloride
TS1119663519	treatedDisease 913 930	diabetes mellitus
TS919663519	treatedDisease 1166 1174	diabetes
TS1219663519	food 1403 1407	food
TS419663519	food 2086 2090	food
TS1819663519	mealTime 2093 2099	fasted
TS1419663519	mealTime 2103 2106	fed
TS1319663519	mealTime 3112 3119	fasting
TS319663519	mealTime 3226 3229	fed
T1	sideeffect 239 261	diabetic complications
T2	drug 759 766	TRC4186
T3	drugEffect 786 809	AGE-breaking activities
R1	has_effect Arg1:T2 Arg2:T3	
T4	drug 1004 1011	TRC4186
T5	sideeffect 455 468	pro-oxidative
T6	sideeffect 436 452	pro-inflammatory
T7	drug 1266 1273	TRC4186
T8	drug 1520 1527	TRC4186
T9	drug 1674 1681	TRC4186
T10	dosage 1695 1709	250 to 2500 mg
T11	dosage 1926 1940	500 to 2000 mg
T12	drug 1905 1912	TRC4186
T13	frequency 1941 1952	twice daily
T14	duration 1953 1963	for 6 days
T15	drug 2153 2160	TRC4186
T16	dosage 2161 2167	500 mg
T17	drug 2312 2319	TRC4186
T18	dosage 2320 2326	500 mg
T19	drug 2339 2346	TRC4186
T20	drug 2417 2424	TRC4186
T21	drug 2545 2552	TRC4186
T22	dosage 2347 2354	1000 mg
T23	sideeffect 2454 2468	adverse events
T24	dosage 2760 2771	250-2500 mg
T25	dosage 2794 2805	500-2000 mg
T26	frequency 2830 2841	twice-daily
T27	drug 3045 3052	TRC4186
R2	relation Arg1:TS1319663519 Arg2:T27	
R3	decrease_absorption Arg1:TS319663519 Arg2:T27	
T28	drug 3424 3431	TRC4186
T29	modeadm 3478 3484	orally
T30	drug 3632 3639	TRC4186
